study evaluates adding radiotherapy to atezolizumab, bevacizumab in hcc
Published 9 months ago • 24 plays • Length 2:01Download video MP4
Download video MP3
Similar videos
-
1:04
dr. lee on trial data evaluating the atezolizumab/bevacizumab in unresectable hcc
-
1:30
dr. overman on the combination of atezolizumab and bevacizumab in hcc
-
2:40
key outcomes of the phase 1b of atezolizumab and bevacizumab for advanced hcc
-
3:42
imbrave050: adjuvant atezolizumab with bevacizumab in high-risk hcc
-
1:12
ahmed kaseb, md, elaborates on the phase 1b study investigating atezolizumab bevacizumab in hcc
-
5:12
safety and efficacy of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma
-
3:15
dr. timothy brown on radiation plus atezolizumab and bevacizumab for advanced hcc at asco gi 2024
-
0:37
combination atezolizumab plus bevacizumab improved quality of life in hcc
-
4:03
real-world outcomes of patients with hcc treated with lenvatinib vs. atezolizumab plus bevacizumab
-
0:59
ffcd 1709-sirtci: selective internal radiation therapy xelox, bevacizumab and atezolizumab in mcrc
-
23:25
dr bharat | role of tecentriq atezolizumab avastin bevacizumab as 1l in unresectable hcc
-
2:30
outcomes with multikinase inhibitors after progression on first-line atezolizumab-bevacizumab in hcc
-
1:03
dr. pishvaian discusses atezolizumab plus bevacizumab in hcc
-
10:42
first-line atezolizumab with bevacizumab for hcc
-
2:05
dr. bekaii-saab on the rationale to evaluate atezolizumab/bevacizumab in mss mcrc
-
4:23
howard hochster, md, on whether atezolizumab bevacizumab regimen is a new standard in care in hcc
-
0:36
nevena damjanov, md, on the outcomes of combining atezolizumab with bevacizumab in hcc patients
-
5:30
pivotal data supporting first-line atezolizumab/bevacizumab in unresectable hcc
-
1:09
ahmed kaseb, md, considers the effectiveness of bevacizumab atezolizumab in hcc